Skip to main content

and
  1. Article

    Open Access

    Collateral effects of the SARS-CoV-2 pandemic on oncologic surgery in Bavaria

    The ongoing SARS-COV-2 pandemic has severe implications for people and healthcare systems everywhere. In Germany, worry about the consequences of the pandemic led to the deferral of non-emergency surgeries. Tu...

    Thomas Dienemann, Frank Brennfleck, Alexander Dejaco, Robert Grützmann in BMC Surgery (2021)

  2. Article

    Open Access

    Autopsy findings after long-term treatment of COVID-19 patients with microbiological correlation

    Between April and June 2020, i.e., during the first wave of pandemic coronavirus disease 2019 (COVID-19), 55 patients underwent long-term treatment in the intensive care unit at the University Hospital of Rege...

    Katja Evert, Thomas Dienemann, Christoph Brochhausen, Dirk Lunz in Virchows Archiv (2021)

  3. Article

    Open Access

    Viral infiltration of pancreatic islets in patients with COVID-19

    Metabolic diseases are associated with an increased risk of severe COVID-19 and conversely, new-onset hyperglycemia and complications of preexisting diabetes have been observed in COVID-19 patients. Here, we p...

    Charlotte Steenblock, Stefanie Richter, Ilona Berger in Nature Communications (2021)

  4. Article

    Open Access

    Retinal neurodegeneration in patients with end-stage renal disease assessed by spectral-domain optical coherence tomography

    Spectral-domain optical coherence tomography (SD-OCT) represents a reliable tool for retinal layer volume and thickness measurement. The aim of this study was to evaluate retinal changes indicating neurodegene...

    Susanne Jung, Agnes Bosch, Christian Ott, Dennis Kannenkeril in Scientific Reports (2020)

  5. Article

    Open Access

    How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial

    Empagliflozin has been shown to reduce cardiovascular mortality, but the underlying pathogenetic mechanisms are poorly understood. It was previously demonstrated that empagliflozin improved arterial stiffness.

    Agnes Bosch, Christian Ott, Susanne Jung, Kristina Striepe in Cardiovascular Diabetology (2019)

  6. Article

    Open Access

    International Network of Chronic Kidney Disease cohort studies (iNET-CKD): a global network of chronic kidney disease cohorts

    Chronic kidney disease (CKD) is a global health burden, yet it is still underrepresented within public health agendas in many countries. Studies focusing on the natural history of CKD are challenging to design...

    Thomas Dienemann, Naohiko Fujii, Paula Orlandi, Lisa Nessel in BMC Nephrology (2016)